NJ A1207

Mandates New Jersey Medicaid coverage for ovulation enhancing drugs and related medical services for beneficiaries ages 21-44 experiencing infertility, contingent on federal financial participation

Defines infertility as failure to establish clinical pregnancy after 12 months of unprotected intercourse for ages 21-34, or after 6 months for ages 35-44, with protections ensuring coverage cannot be denied based on relationship status or sexual orientation

Limits covered medical services to office visits, hysterosalpingograms, pelvic ultrasounds, and blood testing

Restricts coverage to three cycles of treatment per lifetime per beneficiary

Takes effect on the first day of the fourth month following enactment and requires the Commissioner of Human Services to apply for necessary federal waivers and adopt implementing regulations